NorthWest Biotherapeutics Inc (NWBO)

[LK-Yako]

Baxers,

I am of the same opinion as you are, to obtain the initial approval of DCVax-L using the artisan method.
If NICE doesn’t approve the higher cost of manual manufacturing, then the patients would have to pay for it until such time when FW receives approval? How does that sit with their method of paying for medical costs? It would seem rather strange to give approval for treatment and choose not to pay for it because the cost is too high.
Given this line of thinking, NICE would start paying for the cost of DCVax-L treatment when FW receives approval? Just thinking out loud.